Sirolimus, Tacrolimus, and rabbit ATG (r-ATG) as Graft-Versus-Host Disease Prophylaxis in Patients Undergoing Unrelated Donor Peripheral Blood Hematopoietic Cell Transplant (HCT): Extended Follow Up and Updated Analysis

MLA

Ji-Lian Cai, et al. “Sirolimus, Tacrolimus, and Rabbit ATG (r-ATG) as Graft-Versus-Host Disease Prophylaxis in Patients Undergoing Unrelated Donor Peripheral Blood Hematopoietic Cell Transplant (HCT): Extended Follow Up and Updated Analysis.” Biology of Blood and Marrow Transplantation, vol. 17, Feb. 2011, p. S330. EBSCOhost, https://doi.org/10.1016/j.bbmt.2010.12.529.

APA

Ji-Lian Cai, A P Nademanee, Vinod Pullarkat, David S. Snyder, Joycelynne Palmer, Samer K. Khaled, Ryotaro Nakamura, S.J. Forman, David Senitzer, & Pablo M. Parker. (2011). Sirolimus, Tacrolimus, and rabbit ATG (r-ATG) as Graft-Versus-Host Disease Prophylaxis in Patients Undergoing Unrelated Donor Peripheral Blood Hematopoietic Cell Transplant (HCT): Extended Follow Up and Updated Analysis. Biology of Blood and Marrow Transplantation, 17, S330. https://doi.org/10.1016/j.bbmt.2010.12.529

Chicago

Ji-Lian Cai, A P Nademanee, Vinod Pullarkat, David S. Snyder, Joycelynne Palmer, Samer K. Khaled, Ryotaro Nakamura, S.J. Forman, David Senitzer, and Pablo M. Parker. 2011. “Sirolimus, Tacrolimus, and Rabbit ATG (r-ATG) as Graft-Versus-Host Disease Prophylaxis in Patients Undergoing Unrelated Donor Peripheral Blood Hematopoietic Cell Transplant (HCT): Extended Follow Up and Updated Analysis.” Biology of Blood and Marrow Transplantation 17 (February): S330. doi:10.1016/j.bbmt.2010.12.529.